Compulsory Licensing | Intellepedia

Compulsory licensing in copyrights, Al Hamd challenges PPL’s fees

This post examines Al Hamd Tradenation’s challenge to PPL’s license fee structure under Section 31 of the Copyright Act. The Delhi High Court has deferred a final decision, keeping all issues open for future consideration.

After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more

Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO’s decision on double patenting, updates from the IP5 meeting on AI patents, and new initiatives by WHO, WTO, and WIPO.

In Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other Technologies

The article examines India’s policy on compulsory licensing for COVID-related medical technologies, echoing Prof. Arul Scaria’s critique of current government inaction. It highlights the legal and historical basis for compulsory licensing and argues for its strategic use to ensure public access to vaccines and medicines.

Supreme Court restores order extending time limits indefinitely, asks why Government is not invoking compulsory licensing provisions and more

The Supreme Court has indefinitely extended limitation periods for legal proceedings in view of the COVID-19 situation and questioned the Government’s approach to compulsory licensing of essential medicines. India also features on the US Special 301 Report’s Priority Watch List, while the USPTO is hosting free design patent webinars.

Delhi High Court asks government to consider issuing compulsory licenses, World IP day 2021, a solemn affair this year, India – South Africa patent waiver proposal opposed again and more

The Delhi High Court has advised the government to consider compulsory licensing of COVID-19 treatments, reflecting the urgent need for wider access. This post also covers the global debate on patent waivers and the observance of World IP Day 2021, with a focus on recent legal and policy updates.

Intellectual Property, Accessibility and Public health

This analysis explores the relationship between intellectual property, accessibility, and public health, with a focus on recent global developments amid COVID-19. It highlights key policy measures, compulsory licensing, and collaborative efforts to promote access to medical technologies.

Compulsory Licensing in India – Talk by Gaurav Mishra

Mr. Gaurav Mishra presented an in-depth session on compulsory licensing in India under the Patents Act at a DST Rajasthan event. The talk covered legal provisions, case studies, and the significance of compulsory licensing during the COVID-19 pandemic.

COVID crisis threatens Gilead’s patent on Remdesvir, EPO’s Enlarged Board of Appeal issues opinion on plant and animal patentability, India asks G20 to establish agreement enabling use of TRIPS flexibilities and other patent news

The post analyses patent law updates relating to COVID-19, including India’s push for TRIPS flexibilities and scrutiny of Gilead’s Remdesvir patent. It also covers the EPO’s stance on plant and animal patentability and new global initiatives in IP law enforcement.

The IP Choices We Make Today Will Shape our Tomorrow

This post discusses the crucial role of intellectual property choices during the COVID-19 crisis. It calls for balanced policies and open collaboration to foster innovation and ensure access in India.

Preference for Collaborative and Open COVID Innovation and Creativity

The post explores the preference for collaborative and open innovation during the COVID-19 crisis, detailing the decline in IP filings and the shift away from IP exclusivity. It analyses legal measures and global initiatives that promote sharing and accessibility for COVID-related technologies and research.